[2] Karmanos has one of the largest clinical trials programs in the nation, giving patients access to more than 250 treatments.

[9] The institute has a Phase 1 program, a participating site in the Early Therapeutics Clinical Trials Network (ET-CTN) of the NCI.

[8] In 2018, Karmanos was named one of America's Best Hospitals for Cancer Care & Research by the Women's Choice Award.

Previously, Karmanos had been ranked as one of America's Best Hospitals for Cancer Care by the Women's Choice Award, from 2011-2012, as well as 2014-2017.

[11] The Institute is under the direction of President and CEO Boris C. Pasche, M.D., Ph.D., FACP [12] Brian Gamble is president of Barbara Ann Karmanos Cancer Hospital & Network, overseeing clinical operations in Detroit, as well as the Karmanos cancer network across Michigan.